“Monoclonal Antibody Therapy of T Cell Lymphoma: Single Agent Trials of Anti-CD2 (Siplizumab) and Anti-CD4 (Humax-CD4)”. Hematology Meeting Reports 3, no. 1 (June 11, 2009). Accessed June 2, 2026. https://journals.pagepress.net/hmr/article/view/532.